Cargando…
The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
BACKGROUND: It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes in rela...
Autores principales: | Degens, Juliette H.R.J., Dingemans, Anne‐Marie C., Willemsen, Anna C.H., Gietema, Hester A., Hurkmans, Daan P., Aerts, Joachim G., Hendriks, Lizza E.L., Schols, Annemie M.W.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200425/ https://www.ncbi.nlm.nih.gov/pubmed/33951326 http://dx.doi.org/10.1002/jcsm.12698 |
Ejemplares similares
-
Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study
por: Degens, Juliette, et al.
Publicado: (2020) -
Identification of microRNAs in skeletal muscle associated with lung cancer cachexia
por: van de Worp, Wouter R.P.H., et al.
Publicado: (2019) -
Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer
por: Sanders, Karin J C, et al.
Publicado: (2019) -
Nutritional advances in patients with respiratory diseases
por: Schols, Annemie M.W.J.
Publicado: (2015) -
Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia
por: Cortiula, Francesco, et al.
Publicado: (2022)